Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:03 PM
Ignite Modification Date:
2025-12-24 @ 5:03 PM
NCT ID:
NCT04818450
Eligibility Criteria:
Inclusion Criteria:
* Adults (18 years and older)
* Patients admitted to ICU not more than 24 hours at the time of randomization
Exclusion Criteria:
* Patients admitted to ICU less than 72 hours
* Patients receiving gabapentin within 14 days prior to randomization
* Patients receiving restorative drug (trazodone, mirtazapine, olanzapine, agomelatine, and pregabalin) within 7 days prior to randomization
* Patients having contraindications to gabapentin
* Patients receiving high dose vasopressors more than 1 hour during ICU admissions
* Patients presenting with severe respiratory failure (PF ratio \< 100)
* Patients presenting with RASS \< -2 at the time of randomization
* Patients having target RASS of \<-2 during ICU admissions
* Terminal ill patients
* Pregnancy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04818450
Study Brief:
Protocol Section:
NCT04818450